Sucrose density gradient analysis of 1,25-dihydroxyvitamin D3 binding in human breast tumors

S. Christakos, A. Sori, Stuart M. Greenstein, T. F. Murphy

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The object of this investigation was to detect the type and number of 1,25-dihydroxyvitamin D3 [1,25-(OH)2-D3]-binding proteins present in breast tumor and thus to assess, by using sucrose density gradient analysis, the significance of the presence of 1,25-(OH)2D3 binding in breast tumors. Cytosol fractions from 25 tumors (24 malignant breast tumors and 1 benign breast mass) were analyzed for the binding of vitamin D3 metabolites by sucrose density gradient ultracentrifugation. Cytosol fractions from 13 breast tumors exhibited binding of 1,25-(OH)2D3 to a 4.1S macromolecule. Only 5 of the tumors (20%) showed a specific binding protein for 1,25- (OH)2D3, which had a sedimentation coefficient of 3.2-3.4S, similar to that of the 1,25-(OH)2D3 receptor protein found in intestinal cytosol. However, levels below 8 fmol/mg protein were observed for the positive malignant tumors compared to receptor concentrations of 286-563 fmol/mg protein which have been reported for the adult mammalian intestine. No correlation was found between the presence or absence of a specific 3.2-3.4S binding protein and the levels of estrogen receptors. Two of the breast tumors showed binding of 1,25-(OH)2D3 to the 5-6S 25-hydroxyvitamin D3-binding protein. Cytosol, fractionated by precipitation with ammonium sulfate at 40% saturation in order to reduce interference from either the 5-6S binding protein or the 4.1S complex, showed no specific binding of 1,25-(OH)2D3. Rachitic chick intestinal cytosol, vitamin D-deficient rat intestinal cytosol, and cytosol from MCF 7 cells, used as positive controls, consistently exhibited the characteristic 3.2-3.6S receptor. We conclude, due to a heterogeneous cellular population and possible serum contamination in human breast tumors, that the characterization of 1,25-(OH)2D3 receptors in breast cancer cells compared to normal cells may provide more definitive conclusions concerning the relationship between 1,25-(OH)2D3 receptors and malignancy.

Original languageEnglish (US)
Pages (from-to)686-691
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume56
Issue number4
StatePublished - 1983
Externally publishedYes

Fingerprint

Calcitriol
Cytosol
Sucrose
Tumors
Breast Neoplasms
Carrier Proteins
Neoplasms
Calcifediol
Rickets
Proteins
Cholecalciferol
Ultracentrifugation
MCF-7 Cells
Ammonium Sulfate
Vitamin D
Estrogen Receptors
Intestines
Breast
Metabolites
Macromolecules

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Sucrose density gradient analysis of 1,25-dihydroxyvitamin D3 binding in human breast tumors. / Christakos, S.; Sori, A.; Greenstein, Stuart M.; Murphy, T. F.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 56, No. 4, 1983, p. 686-691.

Research output: Contribution to journalArticle

@article{254d0e9aa7684cebae82250db77fbe21,
title = "Sucrose density gradient analysis of 1,25-dihydroxyvitamin D3 binding in human breast tumors",
abstract = "The object of this investigation was to detect the type and number of 1,25-dihydroxyvitamin D3 [1,25-(OH)2-D3]-binding proteins present in breast tumor and thus to assess, by using sucrose density gradient analysis, the significance of the presence of 1,25-(OH)2D3 binding in breast tumors. Cytosol fractions from 25 tumors (24 malignant breast tumors and 1 benign breast mass) were analyzed for the binding of vitamin D3 metabolites by sucrose density gradient ultracentrifugation. Cytosol fractions from 13 breast tumors exhibited binding of 1,25-(OH)2D3 to a 4.1S macromolecule. Only 5 of the tumors (20{\%}) showed a specific binding protein for 1,25- (OH)2D3, which had a sedimentation coefficient of 3.2-3.4S, similar to that of the 1,25-(OH)2D3 receptor protein found in intestinal cytosol. However, levels below 8 fmol/mg protein were observed for the positive malignant tumors compared to receptor concentrations of 286-563 fmol/mg protein which have been reported for the adult mammalian intestine. No correlation was found between the presence or absence of a specific 3.2-3.4S binding protein and the levels of estrogen receptors. Two of the breast tumors showed binding of 1,25-(OH)2D3 to the 5-6S 25-hydroxyvitamin D3-binding protein. Cytosol, fractionated by precipitation with ammonium sulfate at 40{\%} saturation in order to reduce interference from either the 5-6S binding protein or the 4.1S complex, showed no specific binding of 1,25-(OH)2D3. Rachitic chick intestinal cytosol, vitamin D-deficient rat intestinal cytosol, and cytosol from MCF 7 cells, used as positive controls, consistently exhibited the characteristic 3.2-3.6S receptor. We conclude, due to a heterogeneous cellular population and possible serum contamination in human breast tumors, that the characterization of 1,25-(OH)2D3 receptors in breast cancer cells compared to normal cells may provide more definitive conclusions concerning the relationship between 1,25-(OH)2D3 receptors and malignancy.",
author = "S. Christakos and A. Sori and Greenstein, {Stuart M.} and Murphy, {T. F.}",
year = "1983",
language = "English (US)",
volume = "56",
pages = "686--691",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Sucrose density gradient analysis of 1,25-dihydroxyvitamin D3 binding in human breast tumors

AU - Christakos, S.

AU - Sori, A.

AU - Greenstein, Stuart M.

AU - Murphy, T. F.

PY - 1983

Y1 - 1983

N2 - The object of this investigation was to detect the type and number of 1,25-dihydroxyvitamin D3 [1,25-(OH)2-D3]-binding proteins present in breast tumor and thus to assess, by using sucrose density gradient analysis, the significance of the presence of 1,25-(OH)2D3 binding in breast tumors. Cytosol fractions from 25 tumors (24 malignant breast tumors and 1 benign breast mass) were analyzed for the binding of vitamin D3 metabolites by sucrose density gradient ultracentrifugation. Cytosol fractions from 13 breast tumors exhibited binding of 1,25-(OH)2D3 to a 4.1S macromolecule. Only 5 of the tumors (20%) showed a specific binding protein for 1,25- (OH)2D3, which had a sedimentation coefficient of 3.2-3.4S, similar to that of the 1,25-(OH)2D3 receptor protein found in intestinal cytosol. However, levels below 8 fmol/mg protein were observed for the positive malignant tumors compared to receptor concentrations of 286-563 fmol/mg protein which have been reported for the adult mammalian intestine. No correlation was found between the presence or absence of a specific 3.2-3.4S binding protein and the levels of estrogen receptors. Two of the breast tumors showed binding of 1,25-(OH)2D3 to the 5-6S 25-hydroxyvitamin D3-binding protein. Cytosol, fractionated by precipitation with ammonium sulfate at 40% saturation in order to reduce interference from either the 5-6S binding protein or the 4.1S complex, showed no specific binding of 1,25-(OH)2D3. Rachitic chick intestinal cytosol, vitamin D-deficient rat intestinal cytosol, and cytosol from MCF 7 cells, used as positive controls, consistently exhibited the characteristic 3.2-3.6S receptor. We conclude, due to a heterogeneous cellular population and possible serum contamination in human breast tumors, that the characterization of 1,25-(OH)2D3 receptors in breast cancer cells compared to normal cells may provide more definitive conclusions concerning the relationship between 1,25-(OH)2D3 receptors and malignancy.

AB - The object of this investigation was to detect the type and number of 1,25-dihydroxyvitamin D3 [1,25-(OH)2-D3]-binding proteins present in breast tumor and thus to assess, by using sucrose density gradient analysis, the significance of the presence of 1,25-(OH)2D3 binding in breast tumors. Cytosol fractions from 25 tumors (24 malignant breast tumors and 1 benign breast mass) were analyzed for the binding of vitamin D3 metabolites by sucrose density gradient ultracentrifugation. Cytosol fractions from 13 breast tumors exhibited binding of 1,25-(OH)2D3 to a 4.1S macromolecule. Only 5 of the tumors (20%) showed a specific binding protein for 1,25- (OH)2D3, which had a sedimentation coefficient of 3.2-3.4S, similar to that of the 1,25-(OH)2D3 receptor protein found in intestinal cytosol. However, levels below 8 fmol/mg protein were observed for the positive malignant tumors compared to receptor concentrations of 286-563 fmol/mg protein which have been reported for the adult mammalian intestine. No correlation was found between the presence or absence of a specific 3.2-3.4S binding protein and the levels of estrogen receptors. Two of the breast tumors showed binding of 1,25-(OH)2D3 to the 5-6S 25-hydroxyvitamin D3-binding protein. Cytosol, fractionated by precipitation with ammonium sulfate at 40% saturation in order to reduce interference from either the 5-6S binding protein or the 4.1S complex, showed no specific binding of 1,25-(OH)2D3. Rachitic chick intestinal cytosol, vitamin D-deficient rat intestinal cytosol, and cytosol from MCF 7 cells, used as positive controls, consistently exhibited the characteristic 3.2-3.6S receptor. We conclude, due to a heterogeneous cellular population and possible serum contamination in human breast tumors, that the characterization of 1,25-(OH)2D3 receptors in breast cancer cells compared to normal cells may provide more definitive conclusions concerning the relationship between 1,25-(OH)2D3 receptors and malignancy.

UR - http://www.scopus.com/inward/record.url?scp=0020693202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020693202&partnerID=8YFLogxK

M3 - Article

C2 - 6300161

AN - SCOPUS:0020693202

VL - 56

SP - 686

EP - 691

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -